The reciprocal chromosomal translocation t(9; 22) results in the highly stable, constitutively active tyrosine kinase BCR/ABL, which inhibits apoptosis and triggers malignant transformation of chronic myelogenous leukemia (CML). This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.